Cargando…
Resolution of Racemic Guaifenesin Applying a Coupled Preferential Crystallization-Selective Dissolution Process: Rational Process Development
[Image: see text] Preferential crystallization is a cost efficient method to provide pure enantiomers from a racemic mixture of a conglomerate forming system. Exploiting small amounts of pure crystals of both enantiomers, several batch or continuous processes were developed, capable of providing bot...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493326/ https://www.ncbi.nlm.nih.gov/pubmed/32952448 http://dx.doi.org/10.1021/acs.cgd.8b01660 |
_version_ | 1783582544851107840 |
---|---|
author | Temmel, Erik Eicke, Matthias J. Cascella, Francesca Seidel-Morgenstern, Andreas Lorenz, Heike |
author_facet | Temmel, Erik Eicke, Matthias J. Cascella, Francesca Seidel-Morgenstern, Andreas Lorenz, Heike |
author_sort | Temmel, Erik |
collection | PubMed |
description | [Image: see text] Preferential crystallization is a cost efficient method to provide pure enantiomers from a racemic mixture of a conglomerate forming system. Exploiting small amounts of pure crystals of both enantiomers, several batch or continuous processes were developed, capable of providing both species. However, an intermediate production step has to be used when pure enantiomers are not available. In such cases, partially selective synthesis, chromatography, or crystallization processes utilizing chiral auxiliaries have to be used to provide the initial seed material. Recently, it was shown that a coupled Preferential Crystallization-selective Dissolution process (CPCD) in two coupled crystallizers can be applied if at least one pure enantiomer is available to produce both antipodes within one batch. The corresponding process is carried out in one reactor (crystallization tank) by seeding a racemic supersaturated solution with the available enantiomer at a certain temperature. The second reactor (dissolution tank) contains a saturated racemic suspension at a higher temperature. Both reactors are coupled via the fluid phase, allowing for a selective dissolution of the preferentially crystallizing enantiomer from the solid racemic feed provided in the dissolution vessel. The dissolution and crystallization processes continue until the solid racemic material is completely resolved and becomes enantiopure. At this point, both enantiomers can be harvested in their pure crystalline form. For a specific pharmaceutically relevant case study, a rational process design and the applied empirical optimization procedure will be described. The achieved productivities after optimization show the great potential of this approach also for industrial applications. Also, a strategy to control this process based on inline turbidity measurement will be presented. |
format | Online Article Text |
id | pubmed-7493326 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-74933262020-09-16 Resolution of Racemic Guaifenesin Applying a Coupled Preferential Crystallization-Selective Dissolution Process: Rational Process Development Temmel, Erik Eicke, Matthias J. Cascella, Francesca Seidel-Morgenstern, Andreas Lorenz, Heike Cryst Growth Des [Image: see text] Preferential crystallization is a cost efficient method to provide pure enantiomers from a racemic mixture of a conglomerate forming system. Exploiting small amounts of pure crystals of both enantiomers, several batch or continuous processes were developed, capable of providing both species. However, an intermediate production step has to be used when pure enantiomers are not available. In such cases, partially selective synthesis, chromatography, or crystallization processes utilizing chiral auxiliaries have to be used to provide the initial seed material. Recently, it was shown that a coupled Preferential Crystallization-selective Dissolution process (CPCD) in two coupled crystallizers can be applied if at least one pure enantiomer is available to produce both antipodes within one batch. The corresponding process is carried out in one reactor (crystallization tank) by seeding a racemic supersaturated solution with the available enantiomer at a certain temperature. The second reactor (dissolution tank) contains a saturated racemic suspension at a higher temperature. Both reactors are coupled via the fluid phase, allowing for a selective dissolution of the preferentially crystallizing enantiomer from the solid racemic feed provided in the dissolution vessel. The dissolution and crystallization processes continue until the solid racemic material is completely resolved and becomes enantiopure. At this point, both enantiomers can be harvested in their pure crystalline form. For a specific pharmaceutically relevant case study, a rational process design and the applied empirical optimization procedure will be described. The achieved productivities after optimization show the great potential of this approach also for industrial applications. Also, a strategy to control this process based on inline turbidity measurement will be presented. American Chemical Society 2019-05-01 2019-06-05 /pmc/articles/PMC7493326/ /pubmed/32952448 http://dx.doi.org/10.1021/acs.cgd.8b01660 Text en Copyright © 2019 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited. |
spellingShingle | Temmel, Erik Eicke, Matthias J. Cascella, Francesca Seidel-Morgenstern, Andreas Lorenz, Heike Resolution of Racemic Guaifenesin Applying a Coupled Preferential Crystallization-Selective Dissolution Process: Rational Process Development |
title | Resolution of Racemic Guaifenesin Applying a Coupled
Preferential Crystallization-Selective Dissolution Process: Rational
Process Development |
title_full | Resolution of Racemic Guaifenesin Applying a Coupled
Preferential Crystallization-Selective Dissolution Process: Rational
Process Development |
title_fullStr | Resolution of Racemic Guaifenesin Applying a Coupled
Preferential Crystallization-Selective Dissolution Process: Rational
Process Development |
title_full_unstemmed | Resolution of Racemic Guaifenesin Applying a Coupled
Preferential Crystallization-Selective Dissolution Process: Rational
Process Development |
title_short | Resolution of Racemic Guaifenesin Applying a Coupled
Preferential Crystallization-Selective Dissolution Process: Rational
Process Development |
title_sort | resolution of racemic guaifenesin applying a coupled
preferential crystallization-selective dissolution process: rational
process development |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493326/ https://www.ncbi.nlm.nih.gov/pubmed/32952448 http://dx.doi.org/10.1021/acs.cgd.8b01660 |
work_keys_str_mv | AT temmelerik resolutionofracemicguaifenesinapplyingacoupledpreferentialcrystallizationselectivedissolutionprocessrationalprocessdevelopment AT eickematthiasj resolutionofracemicguaifenesinapplyingacoupledpreferentialcrystallizationselectivedissolutionprocessrationalprocessdevelopment AT cascellafrancesca resolutionofracemicguaifenesinapplyingacoupledpreferentialcrystallizationselectivedissolutionprocessrationalprocessdevelopment AT seidelmorgensternandreas resolutionofracemicguaifenesinapplyingacoupledpreferentialcrystallizationselectivedissolutionprocessrationalprocessdevelopment AT lorenzheike resolutionofracemicguaifenesinapplyingacoupledpreferentialcrystallizationselectivedissolutionprocessrationalprocessdevelopment |